Role of cytokines genes polymorphisms in predicting the outcome of HLA matched sibling bone marrow transplantation / Abdallah Mohamed Gamil Abdallah ; Supervised Azza Mahmoud Kamel , Raafat M. Abdelfattah , Gamal Thabet Ali
Material type:
- التنوع فى جينات المحركات الخلوية و دورها فى التنبؤ بنتيجة زرع النخاع بين الأشقاء المتماثلين [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.03.Ph.D.2015.Ab.R (Browse shelf(Opens below)) | Not for loan | 01010110067282000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.03.Ph.D.2015.Ab.R (Browse shelf(Opens below)) | 67282.CD | Not for loan | 01020110067282000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Clinical Pathology
Graft versus host disease (GVHD) is the major complication of allogeneic hematopoietic stem cell transplantation (HSCT) and cytokines are recognized as important mediators of GVHD. Polymorphisms in the regulatory regions of several cytokine genes have been associated with a number of immune diseases as well as post HSCT complications. The aim of this study was the detection of cytokines genes polymorphisms (CGPs) and their relation to post HSCT complications mainly GVHD in Egyptian patients receiving HSCT. The study included 106 patient/donor pairs who received peripheral blood stem cell transplantation (PBSCT) from HLA-matched identical siblings. DNA for cytokine genotyping was available for 105 patients and 98 donors only. Polymerase chain reaction with sequence specific primers (PCR-SSP) technique was used to analyze the following cytokines genotypes: Tumor necrosis factor-alpha (TNF-Ü) ({u2212}308), transforming growth factor beta1 (TGF-Ý1) (codon10 and codon 25), interleukin (IL)-6 ({u2212}174), IL-10 ({u2212}1082, {u2212}819 and {u2212}592) and Interferon {u2013}gamma (IFN-Þ) (+874). From the current study we can conclude that there was no impact of all tested CGPs on development of GVHD or other post HSCT complications.
Issued also as CD
There are no comments on this title.